Physical Therapists in South Pasadena, FL Accepting Medicare
7 Physical Therapists found. Showing 1 - 7
 Ms. Anne-marie Belott, MSPT Physical Therapist - Orthopedic Medicare: Medicare Enrolled Practice Location: 1615 Pasadena Ave S Ste 150, South Pasadena, FL 33707 Phone: 727-527-5272 Fax: 727-522-7412 |
Dr. Autumn Breanne Hanson, PT,DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1501 Pasadena Ave S, South Pasadena, FL 33707 Phone: 727-381-1000 |
 Dylan Shaw, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1615 Pasadena Ave S Ste 150, South Pasadena, FL 33707 Phone: 813-978-9700 |
Mark H Routman, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1615 Pasadena Ave S Ste 150, South Pasadena, FL 33707 Phone: 813-978-9700 |
Ann Schweitzer Kimbrough, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 761 Oleander Way S, South Pasadena, FL 33707 Phone: 727-599-8840 |
Rachel Calcaterra, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1820 Shore Dr S, South Pasadena, FL 33707 Phone: 727-851-9805 |
Tyler Jay Burdsall, PT, DPT Physical Therapist - Orthopedic Medicare: Medicare Enrolled Practice Location: 1615 Pasadena Ave S Ste 150, South Pasadena, FL 33707 Phone: 813-978-9700 Fax: 813-558-6185 |
News Archive
Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.
Additional data from Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease presented
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
NPR interviews First Lady of Haiti about country's progress against HIV
As delegates from around the world convene for the XIX International AIDS Conference (AIDS 2012), NPR correspondent Michel Martin "speaks to Haiti's First Lady Sophia Martelly about the Caribbean island's progress against the epidemic and challenges that persist" in this interview from NPR's "Tell Me More."
Transplant patients suffering from anemia have a greater mortality rate
According to a new study in American Journal of Transplantation, kidney transplant patients suffering from anemia, a treatable blood deficiency, are more likely to die or suffer from organ failure than other transplant recipients.
› Verified 1 days ago
Occupational Therapists
Physical Therapists
Podiatrists
Speech-Language Pathologists
Audiologists
Chiropractors